Determinants of Persistence and Recovery of Chronic COVID19 Chemosensory Dysfunction
DG Minichetti, A Boyd, E Lemire, J Hacker… - Journal of Allergy and …, 2024 - Elsevier
Background In 2-4% of patients, COVID19 chemosensory dysfunction (CSD) persists
beyond six months, accounting for up to 4 million people in the US. The predictors of …
beyond six months, accounting for up to 4 million people in the US. The predictors of …
Short duration phantosmia changes in a post‐COVID‐19 patient in Bangladesh
MA Amin, S Nahin, J Fardous, MFK Rozars… - Clinical Case …, 2022 - Wiley Online Library
Phantosmia is a condition in perceived odors that do not exist. Given the high outlook and
swift recovery of COVID‐19‐induced olfactory dysfunction, the emphasis should be on …
swift recovery of COVID‐19‐induced olfactory dysfunction, the emphasis should be on …
Short duration Phantosmia changes in a COVID-19 patient in Bangladesh.
MA Amin, S Nahin, J Fardous, MFK Rozars… - Authorea …, 2022 - techrxiv.org
Short duration Phantosmia changes in a COVID-19 patient in Bangladesh. Page 1 P osted on
Authorea 6 F eb 2022 | The cop y righ t holder is the a uthor/funder. All righ ts reserv ed. No …
Authorea 6 F eb 2022 | The cop y righ t holder is the a uthor/funder. All righ ts reserv ed. No …